Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Chu-Chang Ku

Res. Fellow - Infectious Dis. Modelling

United Kingdom

Jump to: Affiliations Research Publications
I joined the School in December 2023. I am a member of the modelling research theme of the NIHR Health Protection Research Unit in Vaccines and Immunisation. My research focuses on the health policy assessment for infectious disease control. I am also interested in modelling health behaviours. Before joining the School, I was a postdoc at Imperial College London. I have a PhD in health economics and decision science from the University of Sheffield.

Affiliations
Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Research
Research Area
Mathematical modelling
Bayesian analysis
Economic evaluation
Health economics
Vaccinations
Disease and Health Conditions
Herpesviruses
Tuberculosis
Country
United Kingdom

Selected Publications
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Harnan, S; Kearns, B; Scope, A; Schmitt, L; Jankovic, D; Hamilton, J; Srivastava, T; Hill, H; KU, CC; Ren, S; Rothery, C; Bojke, L; Sculpher, M; Woods, B;
2024
Health technology assessment (Winchester, England)
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Woods, B; Schmitt, L; Jankovic, D; Kearns, B; Scope, A; Ren, S; Srivastava, T; KU, CC; Hamilton, J; Rothery, C; Bojke, L; Sculpher, M; Harnan, S;
2024
Health technology assessment (Winchester, England)
How many patients are managed by the private healthcare sector? An approach using drug sales data
KU, C-C; Kirankumar, R; Raghuram, R; Nimalan, A;
2023
the Union World Conference on Lung Health
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Reid, M; Agbassi, YJ P; Arinaminpathy, N; Bercasio, A; Bhargava, A; Bhargava, M; Bloom, A; Cattamanchi, A; Chaisson, R; Chin, D; Churchyard, G; Cox, H; Denkinger, CM; Ditiu, L; Dowdy, D; Dybul, M; Fauci, A; Fedaku, E; Gidado, M; Harrington, M; Hauser, J; Heitkamp, P; Herbert, N; Herna Sari, A; Hopewell, P; ... Goosby, E.
2023
Lancet (London, England)
Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics.
Dodd, PJ; Shaweno, D; KU, C-C; Glaziou, P; Pretorius, C; HAYES, RJ; MacPherson, P; Cohen, T; AYLES, H;
2023
Nature communications
Accuracy of computer-aided chest X-ray in community-based tuberculosis screening: Lessons from the 2016 Kenya National Tuberculosis Prevalence Survey.
Mungai, B; Ong'angò, J; KU, CC; Henrion, MY R; Morton, B; Joekes, E; Onyango, E; Kiplimo, R; Kirathe, D; Masini, E; Sitienei, J; Manduku, V; Mugi, B; Squire, SB; MacPherson, P; IMPALA Consortium,;
2022
PLOS global public health
Durations of asymptomatic, symptomatic, and care-seeking phases of tuberculosis disease with a Bayesian analysis of prevalence survey and notification data.
KU, C-C; MacPherson, P; Khundi, M; Nzawa Soko, RH; FEASEY, HR A; Nliwasa, M; HORTON, KC; CORBETT, EL; Dodd, PJ;
2021
BMC Med
Accuracy of computer-aided chest X-ray screening in the Kenya National Tuberculosis Prevalence Survey
Mungai, B; Ong‘angò, J; KU, CC; Henrion, MY R; Morton, B; Joekes, E; Onyango, E; Kiplimo, R; Kirathe, D; Masini, E; Sitienei, J; Manduku, V; Mugi, B; Squire, SB; MacPherson, P;
2021
Cold Spring Harbor Laboratory
Public Health Insight From Excess Mortality During the COVID-19 Pandemic
KU, C-C;
2021
American Journal of Public Health
Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
Soko, RN; BURKE, RM; FEASEY, HR A; Sibande, W; Nliwasa, M; Henrion, MY R; Khundi, M; Dodd, PJ; KU, CC; Kawalazira, G; Choko, AT; Divala, TH; CORBETT, EL; MacPherson, P;
2021
Emerging infectious diseases
See more information
Chu-Chang Ku

Contact

United Kingdom